Based on the growing success of BPMpathway throughout Europe and Asia, we are actively looking for distribution partners in the USA.

BPMpathway is a cost-effective remote patient assessment platform that supports orthopaedic patients through their preparation for surgery at enhanced recovery joint schools, during the acute hospital phase and crucially supports them throughout their rehabilitation, whilst at the same time providing clinicians with the vital data needed to assess their on-going recovery progress.

For any remote assessment tool to work, clinicians must be able to trust the data upon which they base their decisions. This data has to be accurate, repeatable and timely, gathered in a manner that is simple and requires no technical expertise on the part of the patient. It is self-evident that important care decisions can only be made based on the output of a medical-grade device, subjected to rigorous, clinical validation.

BPMpathway is uniquely qualified as being:

• Certified as a CE Class 1 Medical Device, FDA listed and tested to EN 60601-1
• Manufactured to ISO 13485:2016 medical standards
• Validated against OrthoPilot® – the gold standard in orthopaedic measurement
• Piloted across the NHS since 2016

BPMpathway has the potential to deliver massive benefits for clinicians and patients in the USA through: